Producer
Grand Pharmaceutical Group (Grand Pharma)
Grand Pharmaceutical Group (Wuhan, Hubei Province, China; HKEX: 0512; ~HK$10B revenue) is one of China's largest pharmaceutical and chemical companies; its subsidiary Grand Chemical is a major synthetic taurine producer operating from Wuhan's chemical industrial zone. Grand Pharma's taurine production capacity is estimated at 15-20% of global market. Grand Chemical Wuhan uses ethylene oxide-based synthesis and supplies taurine to domestic Chinese energy drink producers (Kangshifu, Nongfu Spring sports drinks) as well as exporting to Western pet food ingredient companies. Grand Pharma's broader portfolio includes traditional Chinese medicine, generic pharmaceuticals, and specialty chemicals — taurine sits within its 'life science chemicals' segment. The Wuhan location is strategically significant: Hubei Province is the global center of taurine synthesis, with Wuhan and Yichang together producing an estimated 50%+ of world taurine.
1
Inputs supplied
1
Goods downstream
1
Facilities
0
Stories
What they make
1 input Grand Pharmaceutical Group (Grand Pharma) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Grand Pharmaceutical Group (Grand Pharma) makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Taurine (Grand Chemical)
25%Generic Pharmaceuticals
40%Traditional Chinese Medicine (TCM)
20%Specialty Chemicals
15%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Origin2023
Grand Pharmaceutical Group was founded in the 1990s in Wuhan, Hubei Province, China as part of the expansion of China's pharmaceutical and chemical industrial base. The company listed on the Hong Kong Stock Exchange (HKEX: 0512) and built a diversified healthcare products portfolio spanning traditional Chinese medicine, generic pharmaceuticals, and specialty life science chemicals. Grand Chemical, the taurine-producing subsidiary, operates from Wuhan's chemical industrial zone — approximately 300km downstream from Yongan Pharmaceutical in Yichang, making Hubei Province home to the world's two largest taurine production facilities. The geographic concentration of global taurine synthesis in a single Chinese province — with Wuhan and Yichang collectively producing an estimated 50%+ of world supply — creates a provincial weather, regulatory, or political risk that would simultaneously affect energy drink, infant formula, and pet food supply chains globally. Grand Pharma's taurine primarily supplies domestic Chinese energy drink brands (Kangshifu, Nongfu Spring sports drinks) and is exported to Western pet food ingredient distributors who require non-Yongan supply diversification. The two Hubei taurine producers are geographic neighbors in the same industrial basin, creating limited true supply chain diversification despite being separate companies.
Grand Pharmaceutical Group ↗